Article Information
History
- May 29, 2020.
Article Versions
- Version 1 (May 26, 2020 - 08:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Scott Sheffield, PhD*,
- Anna York, PhD†,#,
- Nicole Swartwood, MSP‡,
- Alyssa Bilinski, MS§,
- Anne Williamson, MPhil¶ and
- Meagan Fitzpatrick, PhD‖,**
- *Department of Mathematics, Massachusetts Institute of Technology
- †Department of Epidemiology (Microbial Diseases), Yale School of Public Health
- ‡Prevention Policy Modeling Lab, Harvard TH Chan School of Public Health
- §Interfaculty Initiative in Health Policy, Harvard Graduate School of Arts and Sciences
- ¶Barts and the London School of Medicine
- ‖Center for Vaccine Development and Global Health, University of Maryland School of Medicine
- ↵#Corresponding author; email: anna.york{at}yale.edu
↵** This work benefited from comments from members of the COVID-19 Statistics, Policy modeling, and Epidemiology Collective, particularly Dr. Joshua Salomon, Samantha Burn, Monica Farid and Dr. Simon Mongey. This is a working paper and remains in development.